Key facts
- It has raised $6.1M; the latest was Early Stage VC ($2.5M) in Dec 2025.
- Notable investors include Smilegate Investment, Matter (Consulting Services (B2B)), Naver D2 Startup Factory, Acorn Pacific Ventures, Duke University Endowment — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for PranaQ
- ·The full record, as it builds
Funding rounds
No funding rounds for PranaQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PranaQ
Operator of a digital healthcare platform intended to monitor and manage sleep and breathing disorders. The company offers wearable medical devices using AI-based biomedical signal processing to measure sleep quality, blood flow, oxygen saturation, heart rate variability, and respiratory indicators through optical sensing, enabling clinicians, healthcare organizations, and individuals to assess conditions, support treatment decisions, and improve ongoing health management.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 21
- Website
- pranaq.com/
- Ownership
- Privately Held (backing)
PranaQ doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PranaQ shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PranaQ in its N-PORT filings yet. We sweep new filings monthly.